PerZeption’s NEI SBIR grant funds early‑stage development of an optical diagnostic tool for age‑related macular degeneration
Executive summary: PerZeption Inc. was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute for a project titled “Efficient Achromatic and Chromatic Photostress Recovery Assessment for Age-related Macular Degeneration.” The grant provides non‑dilutive federal funding to develop a diagnostic tool that could improve early detection and monitoring of AMD, a leading cause of vision loss.
Who is involved: PerZeption Inc.; National Eye Institute (NEI); the SBIR program.
Likely next: PerZeption will use the funds to build and validate a prototype, with the possibility of applying for Phase II SBIR support or seeking clinical partnerships.
The National Eye Institute’s Phase I SBIR award gives PerZeption non‑dilutive financing to advance a photostress recovery assessment platform aimed at detecting and monitoring age‑related macular degeneration. Such grants are part of a broader federal effort to spur innovation in biomedical optics without diluting founder equity. While the award covers only initial feasibility work, a successful outcome could open the door to Phase II funding, clinical partnerships, or eventual regulatory clearance. At present, the announcement carries limited immediate market or regulatory impact.
What's next — scenarios
Base: Phase I prototype completed (50%)
PerZeption achieves technical milestones and prepares a Phase II SBIR application.
- Prototype meets predefined performance benchmarks
- Positive interim results reported internally
- Submission of Phase II application to NEI
Upside: Strong clinical performance leads to Phase II award (30%)
Accelerated path toward FDA clearance and potential revenue from licensing or device sales.
- Pilot study shows statistically significant improvement in photostress measurement
- At least two ophthalmology centers express interest in collaboration
- NEI announces Phase II SBIR award
Downside: Technical challenges limit follow‑on funding (20%)
Project stalls after Phase I, requiring alternative financing or a strategic pivot.
- Failure to meet prototype performance targets
- No additional SBIR or grant applications submitted
- Negative feedback from early usability testing
Timeline
- — PerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration Study (PR Newswire)